Dr. Stephen Rolfe joined the University of New England, College of Pharmacy in July 2011 as an Assistant Clinical Professor in the Department of Pharmacy Practice. Dr. Rolfe is originally from Millinocket, Maine and received his Doctor of Pharmacy from the University of Rhode Island in 2007. After graduation, he completed a Pharmacy Practice residency at UF Health Jacksonville in Jacksonville, FL followed by a specialty residency in Critical Care at Boston Medical Center in Boston, MA. Prior to joining the University of New England, Dr. Rolfe was a clinical pharmacy specialist in emergency medicine at UMass Memorial Medical Center where he established the first clinical pharmacy service in their Emergency Department. Dr. Rolfe has completed a teaching certificate program from Northeastern University, School of Pharmacy and is a Board Certified Pharmacotherapy Specialist.
Dr. Rolfe's clinical interests include pre-hospital care, trauma critical care, disaster medicine, and clinical toxicology. Academic/research interests include integration of high-fidelity patient simulation into pharmacy education, medication safety in the emergency department, emergency reversal of anticoagulation and acute management of patients with traumatic injuries; Previous research have included the evaluation of pharmacy resident perceptions, knowledge and interventions following a trauma response training program; incidence and rate of antithrombotic errors in the emergency department; and the safety and efficacy of intravenous procainamide for the treatment of recent-onset atrial fibrillation.
Outside of UNE, he enjoys spending time with his wife and kids, playing hockey, mountain biking, and fishing.
University of Rhode Island
Board Certifications and Licenses
Board Certified Pharmacotherapy Specialist
PGY-1 Pharmacy Practice
UF Health Jacksonville
PGY-2 Critical Care Pharmacy
Boston Medical Center
Department of Emergency Medicine, Maine Medical Center
Adult Critical Care/Trauma
Robbins A, Fong J, Hall W, Ditch K, Rolfe S, Miller M. Comparison of a low, fixed dose and a hight, weight-based dose of recombinant factor VIIa in the treatment of warfarin-associated intracranial hemorrhage. Neurocrit Care. 2014;20(3):466-469
Rolfe S, Philips K, Papadopoulos. Controversies in anticoagulation reversal. Journal of Pharmacy Practice. 2010;23:217-225.